GLP-1 drugs could become personalized for individuals, study says

From The Hill

The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.

Source Author
Author: Source Author

Written by

Patrick Djordjevic

in

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts